NIPT
Screen for genetic disorders to best guide your fetus’s health
Non-Invasive Prenatal Screening or NIPT is a non-invasive screening method used to determine the chromosomal abnormalities of the fetus using maternal blood when the gestational age reaches 10-20 weeks.
- Screening for fetal risks of developing chromosomal anomalies
- Screening for certain chromosomes causing congenital disorders or disability
- Reducing the need for unnecessary amniocentesis
- Guiding for a proper pregnancy care and planning
With Whole-Genome Next Generation Sequencing (NGS) technology, the results are highly reliable, precise and accurate with no associated risks for the mother and the fetus.
